Tillotts Pharma Uk Limited WELLINGORE


Founded in 2010, Tillotts Pharma Uk, classified under reg no. 07186552 is an active company. Currently registered at Larbourne Suite The Stables LN5 0HX, Wellingore the company has been in the business for fourteen years. Its financial year was closed on 31st December and its latest financial statement was filed on 2022-12-31.

At the moment there are 3 directors in the the company, namely Marcel P., Barbara L. and Jeremy T.. In addition one secretary - Lisa R. - is with the firm. At the moment there are several former directors listed by the company. Their names might be found in the box below. In addition, there is one former secretary - Helen J. who worked with the the company until 16 March 2020.

Tillotts Pharma Uk Limited Address / Contact

Office Address Larbourne Suite The Stables
Office Address2 Wellingore Hall
Town Wellingore
Post code LN5 0HX
Country of origin United Kingdom

Company Information / Profile

Registration Number 07186552
Date of Incorporation Thu, 11th Mar 2010
Industry Other business support service activities not elsewhere classified
End of financial Year 31st December
Company age 14 years old
Account next due date Mon, 30th Sep 2024 (155 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Mon, 25th Mar 2024 (2024-03-25)
Last confirmation statement dated Sat, 11th Mar 2023

Company staff

Marcel P.

Position: Director

Appointed: 25 March 2022

Barbara L.

Position: Director

Appointed: 27 March 2020

Lisa R.

Position: Secretary

Appointed: 16 March 2020

Jeremy T.

Position: Director

Appointed: 14 May 2013

Helen J.

Position: Director

Appointed: 01 April 2019

Resigned: 31 October 2019

Ingrid E.

Position: Director

Appointed: 02 January 2018

Resigned: 01 September 2019

Helen J.

Position: Secretary

Appointed: 03 August 2016

Resigned: 16 March 2020

Yves K.

Position: Director

Appointed: 31 March 2016

Resigned: 02 January 2018

Aldbury Secretaries Limited

Position: Corporate Secretary

Appointed: 11 March 2010

Resigned: 03 August 2016

Allan C.

Position: Director

Appointed: 11 March 2010

Resigned: 29 August 2012

Thomas T.

Position: Director

Appointed: 11 March 2010

Resigned: 31 March 2016

Olof N.

Position: Director

Appointed: 11 March 2010

Resigned: 25 March 2022

People with significant control

The list of PSCs who own or control the company is made up of 1 name. As we established, there is Zeria Pharmaceutical Co.,Ltd from Tokyo, Japan. This PSC is categorised as "a company limited by shares", has significiant influence or control over the company. This PSC has significiant influence or control over this company,.

Zeria Pharmaceutical Co.,Ltd

10-11 Nihonbashi Kobuna-Cho, Chuo-Ku, Tokyo, Japan

Legal authority Japanese
Legal form Company Limited By Shares
Country registered Japan
Place registered Japan
Registration number 0100-01-034790
Notified on 5 March 2024
Nature of control: significiant influence or control

Annual reports financial information

Profit & Loss
Accounts Information Date 2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Balance Sheet
Cash Bank On Hand2 776 0714 427 1031 341 4171 198 4968 031 6916 203 08612 228 5805 511 546
Current Assets12 736 77413 840 55821 231 32415 980 64132 510 96634 770 02934 467 55631 475 606
Debtors5 041 8284 388 4395 070 4966 807 5196 906 15110 830 1219 601 83118 344 721
Other Debtors1 0331 0331 0331 0331 0331 0331 0331 033
Total Inventories4 918 8755 025 01614 819 4117 974 62617 573 12417 736 82212 637 1457 619 339
Other
Audit Fees Expenses10 00010 00010 00010 30010 30010 60011 20011 760
Audit-related Assurance Services Fees      47 1768 860
Company Contributions To Money Purchase Plans Directors13 25514 18717 35020 15019 40719 40719 40719 407
Director Remuneration182 493180 042192 108239 024211 812228 189244 968256 604
Number Directors Accruing Benefits Under Money Purchase Scheme11121111
Accrued Liabilities Deferred Income734 479465 4901 048 1831 584 6671 265 3921 649 2532 861 4064 247 379
Administrative Expenses4 712 7805 613 0976 302 5406 690 9026 112 8066 975 8648 901 6408 341 797
Amounts Owed By Group Undertakings413 350 78 914   429 270 
Amounts Owed To Group Undertakings8 715 73410 089 65916 017 4619 773 38325 295 33225 566 86422 388 97516 963 716
Applicable Tax Rate2020191919191925
Average Number Employees During Period2328353736374041
Cash Cash Equivalents Cash Flow Value2 776 071 1 341 4171 198 4968 031 6916 203 08612 228 580 
Comprehensive Income Expense680 578503 036830 683707 3811 165 8541 129 5841 232 3061 288 219
Corporation Tax Payable94 27894 71193 80386 045156 683135 49292 909184 454
Cost Sales13 217 74315 710 86218 045 20821 378 95627 176 82829 367 87833 664 22043 143 707
Creditors10 747 56311 348 31117 908 39411 950 33027 314 80128 444 28026 909 50122 629 332
Current Tax For Period142 212174 710183 206165 852273 880265 357289 016403 871
Further Item Interest Expense Component Total Interest Expense55 00053 94431 354391 14329 935313 526450 941824 216
Further Operating Expense Item Component Total Operating Expenses42 48257 22149 36929 1496 49134 61534 61534 615
Future Minimum Lease Payments Under Non-cancellable Operating Leases35 81646 67936 4601 51534 61534 61520 19234 615
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss-5 4696 0662 285-4 4751 2543 275-19 4462 715
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables3 907 5781 600 3156 560 991-6 967 24716 310 774-5 786 8001 097 08410 947 457
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables-872 642653 389-682 057-1 737 023-98 632-3 923 9701 228 290-8 742 890
Gross Profit Loss5 566 5656 305 8917 278 0787 932 2877 376 9468 661 06110 871 96110 755 323
Income Taxes Paid Refund Classified As Operating Activities-91 000-156 358-137 404-173 610-203 242-286 548-331 599-312 326
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation1 597 2521 651 032-3 085 686-142 9216 833 195-1 828 6056 025 494-6 717 034
Increase Decrease In Current Tax From Adjustment For Prior Periods -17 919-46 710   -35 
Increase Decrease In Stocks Inventories Finished Goods Work In Progress2 169 474106 1419 794 395-6 844 7859 598 498163 698-5 099 677-5 017 806
Interest Income On Bank Deposits5 5508013 6593 6551 230160292102 180
Interest Paid Classified As Operating Activities-55 000-53 944-31 354-391 143-29 935-313 526-450 941-824 216
Interest Payable Similar Charges Finance Costs55 00053 94431 354391 14329 935313 526450 941824 216
Merchandise4 918 8755 025 01614 819 4117 974 62617 573 12417 736 82212 637 1457 619 339
Net Cash Flows From Used In Financing Activities 1 000 000 -1 016 9411 016 941-6 937 4702 589 28015 319 171
Net Cash Flows From Used In Investing Activities-5 550-801-3 659-3 655-1 230-160-292-102 180
Net Cash Flows From Used In Operating Activities-1 591 702-2 650 2313 089 3451 163 517-7 848 9068 766 235-8 614 482-8 499 957
Net Cash Generated From Operations-1 737 702-2 860 5332 920 587598 764-8 082 0838 166 161-9 397 022-9 636 499
Net Current Assets Liabilities1 989 2112 492 2473 322 9304 030 3115 196 1656 325 7497 558 0558 846 274
Net Interest Received Paid Classified As Investing Activities-5 550-801-3 659-3 655-1 230-160-292-102 180
Number Shares Issued Fully Paid 20 00020 00020 00020 00020 00020 00020 000
Operating Profit Loss872 240712 970994 8741 260 7211 468 4391 708 3071 971 9712 414 126
Other Interest Receivable Similar Income Finance Income5 5508013 6593 6551 230160292102 180
Other Operating Income Format118 45520 17619 33619 336204 29923 1101 650600
Other Taxation Social Security Payable55 11468 65764 40074 11477 78579 761163 7318 690
Par Value Share 1111111
Pension Other Post-employment Benefit Costs Other Pension Costs73 21383 464110 438120 957123 399147 471167 609159 877
Prepayments Accrued Income200 480156 008153 654219 687246 956379 413133 283212 462
Profit Loss680 578503 036830 683707 3811 165 8541 129 5841 232 3061 288 219
Profit Loss On Ordinary Activities Before Tax822 790659 827967 179873 2331 439 7341 394 9411 521 3221 692 090
Repayments Borrowings Classified As Financing Activities -1 000 000 -7 073 701-1 016 941 -2 589 280-15 319 171
Social Security Costs193 761227 329281 117337 308312 592369 365493 690409 553
Staff Costs Employee Benefits Expense1 831 4292 079 2102 593 0532 768 1972 935 8623 266 1334 038 9593 776 803
Tax Expense Credit Applicable Tax Rate164 558131 965183 764165 914273 549265 039289 051423 023
Tax Increase Decrease From Effect Different Tax Rates On Some Earnings       -19 152
Tax Tax Credit On Profit Or Loss On Ordinary Activities142 212156 791136 496165 852273 880265 357289 016403 871
Total Assets Less Current Liabilities1 989 2112 492 2473 322 9304 030 3115 196 1656 325 7497 558 0558 846 274
Trade Creditors Trade Payables205 933405 701364 16032 86581 821303 538607 728446 485
Trade Debtors Trade Receivables4 426 9654 231 3984 836 8956 586 7996 658 16210 449 6759 038 24518 131 226
Turnover Revenue18 784 30822 016 75325 323 28629 311 24334 553 77438 028 93944 536 18153 899 030
Wages Salaries1 564 4551 768 4172 201 4982 309 9322 499 8712 749 2973 377 6603 207 373
Proceeds From Borrowings Classified As Financing Activities   -8 090 642 -6 937 470  
Tax Increase Decrease From Other Tax Effects Tax Reconciliation  -558-62331   

Company filings

Filing category
Accounts Address Annual return Capital Confirmation statement Document replacement Incorporation Officers
Full accounts data made up to 2022-12-31
filed on: 30th, March 2023
Free Download (22 pages)

Company search

Advertisements